Immucell ICCC
NASDAQ ICCC
$11.42 +0.67 (+6.23%)
At close: Nov 16, 2026 · 4:00 PM EST

Immucell (ICCC) Price to Earnings (2012 - 2026)

Updated

Immucell's Price to Earnings was 47.40 in Q3 2026, up 94.8% from 24.33 a year earlier but down 59.1% from the prior quarter.

Analysis

Immucell (ICCC) Price to Earnings (2012 - 2026) Analysis & Trends

For FY2016, Price to Earnings at Immucell came in at 56.73, up 198.8% from FY2015.

  • In earlier years, Price to Earnings was 18.99 in FY2015, 110.10 in FY2013 (-18.4%) and 134.91 in FY2012.
  • Quarterly Price to Earnings has moved between 24.33 (Q3 2025) and 115.92 (Q2 2026) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Immucell 102.43 Mn 75.03 Mn 3.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 47.40
Jun 30, 2026 115.92
Sep 30, 2025 24.33
Jun 30, 2025 35.74
Mar 31, 2022 53.77
Sep 30, 2021 1,990.55
Sep 30, 2017 578.15
Jun 30, 2017 82.45
Mar 31, 2017 41.88
Dec 31, 2016 56.73
Sep 30, 2016 48.86
Jun 30, 2016 26.62
Mar 31, 2016 24.12
Dec 31, 2015 18.99
Sep 30, 2015 17.23
Jun 30, 2015 33.58
Mar 31, 2015 58.58
Dec 31, 2013 110.10
Sep 30, 2013 56.84
Jun 30, 2013 87.10
API Access

Immucell Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=ICCC&period=max&api_key=YOUR_API_KEY